Anglo American to sell nickel business for $500m

Anglo American is ramping up efforts to streamline its business amid takeover pressure from BHP with the sale of its nickel business.

Mining giant Anglo American has struck a deal to sell its Brazilian nickel business to Asian metals group MMG Limited in a transaction worth up to $500 million.

The sale, announced today, will see MMG acquire Anglo American’s two operating ferronickel facilities in Brazil—Barro Alto and Codemin—along with two undeveloped projects, Jacaré and Morro Sem Boné.

Under the terms of the agreement, Anglo American will receive an initial payment of $350 million when the deal completes. The company could earn an additional $100 million through a price-linked bonus scheme, whilst a further $50 million may be paid if MMG proceeds with developing the greenfield projects.

News of the nickel sale comes a day after Anglo American outlined the timeline for the listing of its platinum business.

“The sale of our nickel business after a highly competitive process marks a further important milestone towards simplifying our portfolio to create a more highly valued copper, premium iron ore, and crop nutrients business,” said Duncan Wanblad, Chief Executive of Anglo American.

“Today’s agreement, together with those signed in November 2024 to sell our steelmaking coal business, is expected to generate a total of up to $5.3 billion of gross cash proceeds, reflecting the high quality of our steelmaking coal and nickel businesses. MMG is well-respected as a safe and responsible operator and we believe our agreement represents a strong outcome not only for our shareholders, but also for our employees and Brazilian stakeholders. We will work together to ensure a successful transition.

“Anglo American’s portfolio focus, exceptional asset quality and growth options offer a differentiated investment proposition for investors. We are unlocking the inherent value of all of Anglo American as we create a much simpler, more resilient and agile business that will enable full value transparency in the market.”

Assura rejects KKR bid

Assura plc has unanimously rejected a takeover proposal from private equity firm KKR, declaring that the offer “materially undervalued” the healthcare property company and its future prospects.

The proposal, which was submitted to Assura’s board on 13 February, outlined a non-binding cash offer of 48 pence per share for the company. KKR has not submitted any revised offers since the rejection.

KKR has already submitted four offers, and one would think they’ll be back again before long with a refreshed bid.

Assura shares are down heavily over the past two years and trade at just 12x earnings with a 7% yield. There’s still plenty of wiggle room for KKR to snap up Assura at bargain prices.

In a related development, USS Investment Management Limited (USSIM), acting on behalf of the Universities Superannuation Scheme, announced it would not pursue an offer for Assura, either independently or as part of a consortium with KKR. This decision is binding except under specific circumstances detailed in USSIM’s separate announcement.

Peer group leading results and the special dividend roadmap with Tekcapital CEO Dr Clifford Gross

The UK Investor Magazine was delighted to welcome Dr Clifford Gross, CEO of Tekcapital, back to the podcast to delve into the technology incubator’s 2024 portfolio results and what could be in store in 2025.

We start by reviewing the portfolio’s performance in 2024, paying particular attention to the impact of MicroSalt and GenIP’s IPOs.

Dr Clifford Gross outlines plans for Guident’s proposed NASDAQ listing and what it means for Tekcapital’s overall strategy.

We finish by exploring the roadmap for Tekcapital to return net asset value growth to shareholders via special dividends.

FTSE 100 ticks higher, BAE Systems soars

The FTSE 100 rallied on Monday amid a broad European rally driven by defence stocks sparked by positioning for greater defence spending.

Donald Trump’s approach to Ukraine peace negotiations has strengthened the argument that Europe must bolster its armed forces with investors quickly buying up defence shares, including London’s BAE Systems and Rolls Royce.

“European markets pushed ahead on Monday amid talk of greater defence spending, M&A activity and a series of important political meetings,” said Russ Mould, investment director at AJ Bell.

“Ukraine peace talks topped the agenda, while Chinese president Xi Jinping undertook a rare meeting with some of China’s biggest tech firms to boost business sentiment.”

BAE Systems was the top FTSE 100 riser as investors tweaked their portfolios to reflect a possible increase in defence spending.

“Comments by secretary general Mark Rutte that NATO members will have to boost their defence spending by ‘considerably more than 3%’ of GDP put a rocket underneath defence stocks. BAE Systems jumped to the top of the FTSE 100 risers list as investors hoped its earnings prospects would be greatly improved. Mid-cap defence player Chemring also enjoyed a boost.

BAE Systems shares surged by 7% while Rolls-Royce gained 3%, reaching an all-time record high.

Away from the defence sector, Barclays and NatWest enjoyed buying pressure following a bout of profit-taking last week. Both banks dipped after releasing their results, but the weakness proved short-lived, with investors piling back in and sending the pair higher by more than 3%.

Barratt Redrow added 1%, and Persimmon was flat after Rightmove said house prices showed signs of slowing, although sales remained robust.

“UK asking prices rose modestly from January to February, slightly below the typical seasonal gain, with the year-on-year increase also slowing according to data from Rightmove,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“Despite this, sales activity remains solid, with strong buyer demand and an uptick in new sellers. After a tough 2024, housebuilders have generally been upbeat about the outlook for 2025, and the steady market activity supports some cautious optimism.”

AIM movers: Springfield Properties land sale and Europa Metals deal terminated

10

Tekcapital (LON: TEK) has published a portfolio update showing the progress made during 2024. This was a period when investee companies MicroSalt (LON: SALT) and GenIP (LON: GNIP) joined AIM. The remaining unquoted investee company Guident is set to join Nasdaq this year. The value of the investment portfolio increased 38% to $64.2m. NAV is 25p/share. The share price improved 9.41% to 10p, which is still a 60% discount to NAV. (see Tekcapital shares gain after releasing portfolio review, reaffirms special dividend strategy – UK Investor Magazine)

Scotland-based housebuilder Springfield Properties (LON: SPR) is selling land holdings in central Scotland to Barratt for £64.2m and could sell further sites. This will contribute a significant profit in the year to May 2025. Springfield Properties will refocus on the north of Scotland. Trading has been weak so far in this financial year. Interim revenues declined 13%, but better margins meant that pre-tax profit recovered from £2m to £3.8m. Singer has downgraded its 2025-26 pre-tax profit forecast by 14% to £14.2m, but the dividend is expected to continue to recover. A net cash position is expected by 2027. The share price rebounded 9.14% to 107.5p.

Thor Energy (LON: THR) has completed the acquisition of 80.2% of Go Exploration and the payment is 466.5 million shares. A further 25 million shares were issued to Orana Corporate for consultancy services. Go Exploration is a hydrogen and helium explorer with a hydrogen and helium exploration licence in South Australia near to the Ramsay-1 and Ramsay-2 discoveries. An independent assessment is due to be published soon. The share price rose 8.33% to 0.65p.

MTI Wireless (MWE) has won a repeat antenna order worth $4m. This will be delivered in the period up to June 2026. The 2024 results will be published on 17 March. The share price increased 3.77% to 55p.

FALLERS

Trading in Europa Metals (LON: EUZ) shares recommenced this morning after the period of exclusivity over the potential purchase of Viridian Metals Ireland, which owns the Tynagh brownfield Pb/Zn/Cu/Ag project in the Republic of Ireland. Europa Metals has been unable to source funding for initial work on the project and is not going ahead with the deal. The share price dipped by one-fifth to 1.6p.

Surgery devices developer Creo Medical (LON: CREO) says core revenues were 74% ahead at £4m in 2024, which is well ahead of the forecast of £3.4m. The distribution operations have been sold leaving the company with net cash. Operating costs were reduced by £5m last year and the full benefit will be in 2025. Creo Medical is expected to remain loss-making, but it will not need to raise additional cash. The share price declined 8.73% to 17.25p.

Orosur Mining (LON: OMI) has completed phase one of its exploration joint venture for the El Pantano gold exploration project in Argentina and has a 51% stake following the $1m investment. Further investment of $2m would mean that Orosur Mining can own 100% of the project. The vendors will retain a 2% net smelter royalty. The plan is to define drill targets. The share price fell 4.05% to 13.625p.

Allergy Therapeutics (LON: AGY) says published data from its phase III G306 study for its grass allergen immunotherapy Grass MATA MPL shows a 20.3% improvement, which is much higher than for trials of other treatments. The treatment requires six injections rather than up to 100 injections and tablets of other treatments. The quality of life improves by 27.7%. A marketing authorisation application has been filed in Germany. The share price slipped 3.85% to 6p, but the share price is still on an upward trend.

Sound Energy (LON: SOU) has appointed Zeus as its nominated adviser and broker. The share price is 3.13% higher at 0.775p.

Tekcapital shares gain after releasing portfolio review, reaffirms special dividend strategy

Tekcapital shares gained on Monday after the UK-based intellectual property investment group issued a year-end portfolio update and affirmed its plans to return capital to shareholders through special dividends.

Tekcapital reported a 38% increase in its investment portfolio value to $64.2 million in 2024, significantly outperforming market benchmarks and peer companies during the year.

The company’s strong performance is reflected in its share price growth of 27% during 2024, substantially outpacing both the AIM All-Share Index, which declined 5.5%, and the FTSE 250, which gained 5.69%.

This growth was driven by achieving key milestones for portfolio companies, including the successful public listing of two portfolio companies, MicroSalt plc and GenIP, on the AIM market.

MicroSalt had a rip-roaring start to life as a listed company, with shares tripling before falling back. The low-sodium salt technology company announced a ten-fold increase in projected volumes at the beginning of 2025, setting MicroSalt up for another promising year of growth.

The company supplies one of the world’s largest snack food companies with its low-sodium products. It has signalled that the relationship is expanding by announcing increased volumes towards the end of last year, which were followed by encouraging projections. The snack food company remains unnamed, presumably due to the commercial sensitivities of adopting MicroSalt’s technology.

GenIP was listed during a challenging period for the wider market in late 2024 and has set about ramping up its AI-enhanced analytics services aimed at the technology transfer industry. GenIP announced a record order and fresh commercial relationships since listing.

With the listing of GenIP and MicroSalt, four out of Tekcapital’s five portfolio companies are now publicly traded, with the fifth company, Guident, the autonomous vehicle safety company, preparing for a NASDAQ listing in 2025.

Guident may prove to be the jewel in Tekcapital’s crown. Tekcapital is preparing to list Guident at a crucial juncture for autonomous vehicles created by the wider adoption of the technology. Peers listing in the US are attracting bumper valuations, and everything points to a very favourable IPO for Guident.

“We are excited to provide this 2024 summary report which describes a few of our portfolio company achievements and their contribution to our profitability and growth. In 2024 our unaudited net assets reached US$65.1m, an increase of ~36%, over the previous year, with an NAV per share of US $0.31 or £0.25,” said Dr. Clifford M. Gross, Chairman.

“Our performance reflects strong commercial progress through the completion of two AIM listings (MicroSalt plc & GenIP plc) which we are keen to hold. As a result of this progress, four of our five portfolio companies are now listed. Additionally, we observed significant commercial traction for Innovative Eyewear Inc. as they achieved several new product and go-to-market milestones. We were also pleased to note Microsalt has received new and follow-on B2B orders from a major snack food manufacturer. Further, we believe that Guident Corp’s commercial advancements coupled with improving market conditions in the autonomous vehicle industry, have created the ideal opportunity for Tekcapital to further crystalise its balance sheet in 2025.

The Tekcapital Chairman continued to explain the group’s strategy and objective to return capital to investors through special dividends:

“Tekcapital’s core business objective is to grow its net assets and return material levels of capital generated from its portfolio companies’ successes to shareholders via special dividends. As ever, we remain committed to this objective, and our portfolio companies’ progress in 2024 means we have taken strides forward in delivering on our long-term strategy,” Gross explained.

Despite Tekcapital’s strong performance, the stock currently trades at a 64% discount to its Net Asset Value (NAV), a larger gap than its industry peers. For comparison, Molten Ventures plc trades at a 52% discount, IP Group plc at 45%, Frontier IP Group plc at 35%, and Mercia Asset Management plc at 25%. The industry average discount for UK closed-end funds in 2024 was 16.6%, according to Morningstar.

This discount may prove to be an opportunity for investors as general market sentiment improves and Tekcapital completes the Guident IPO, which could significantly increase Tek’s net asset value.

In addition, the company maintains a notably efficient operation, with administrative expenses of just US $2.2 million in 2024, the lowest among its peer group. This lean structure, combined with its strategic focus on a select number of portfolio companies, has contributed to its strong financial performance.

Share Tip: Springfield Properties – this morning’s Interims show that this group is moving at quite a pace

Good news always comes out faster than bad news! 
Like the rest of the market, I was looking for the Scottish-based housebuilding and construction group Springfield Properties (LON:SPR) to announce its Interim Results for the six months to end-November 2024 tomorrow morning, as planned. 
However, the group declared them this morning – they were good and better than expected. 
The group also announced that its is selling 2,480 of its building plots to Barratt Redrow for £64.2m. 
Together those two pieces of news should be positive enough to push the shares forward again.&nbs...

Anglo American outlines platinum unit demerger timeline

Mining giant Anglo American has outlined its June timeline for the separation of Anglo American Platinum, following the platinum company’s release of its 2024 annual results.

Anglo American has scrambled to fight off takeover interest from BHP, and this demerger is one measure undertaken in an attempt to keep the Anglo listing going.

The unit will be listed on both the Johannesburg Stock Exchange and the London Stock Exchange, meaning the London-listed AAL entity will retain some exposure to its platinum business.

Anglo American Platinum has declared dividends amounting to R16.5 billion (approximately £0.7 billion), which comprises both a final dividend for 2024 and an additional cash dividend.

These payments will be distributed to all shareholders before the demerger takes place. As Anglo American currently holds approximately 67 per cent of Anglo American Platinum’s shares, it anticipates receiving roughly £0.5 billion from these dividend payments.

Anglo American Platinum reported adjusted EBITDA for 2024 of R19.8 billion, approximately $1.1 billion.

“We are on a clear timeline towards demerging Anglo American Platinum – the world’s leading PGMs producer – in June, with its primary listing on the Johannesburg Stock Exchange and an additional listing on the London Stock Exchange,” said Duncan Wanblad, Chief Executive of Anglo American.

“Consistent with our commitment to deliver a responsible demerger, Anglo American intends to retain a 19.9% shareholding in Anglo American Platinum in order to further help manage flowback by reducing the absolute size of the shareholding that will be demerged. Anglo American will no longer have any representation on the Anglo American Platinum board post demerger and we intend to exit our residual shareholding responsibly over time, and subject to customary lock-up arrangements.”

ASX-listed Wellnex Life set to join AIM

ASX-listed consumer healthcare company Wellnex Life Ltd (ASX: WNX) is planning to gain an additional quotation on AIM. It currently has a market capitalisation of A$20m.
The company was originally a dairy products business but subsequently moved into consumer healthcare. This has been the focus since 2021.
Wellnex Life has an agreement with Haleon to supply paracetamol products under the Panadol brand. This deal has been expanded outside of Australia and includes the UK and the UAE. There are partnerships with other major pharmaceutical companies. Wellnex Life also has its own brand Pain Away,...

Likewise continues to outperform floorcoverings market

Floorcoverings distributor Likewise Group (LON: LIKE) continues to grow market share on the back of rising revenues despite the decline in its underlying markets. Consumer markets remain tough, but Likewise is showing no signs of decline.
Revenues were 8% ahead in January, following a 10% year-on-year improvement in the fourth quarter. Full year revenues of £150.8m for 2024 were 3% ahead of forecast and 8% higher than the previous year. The market may have fallen by as much as 10% last year.  The overall market is worth less than in 2019.
Solihull-based Likewise has been built up via acqu...